Meet Our Expert Providers At myEvergreen MedSpa, your peptide therapy plan will be developed and supervised by highly trained medical professionals specializing in wellness and regenerative treatments
Our protocols account for training periodization, competition schedules, and sport-specific physiological requirements to optimize timing and effectiveness
What is the typical BPC-157 dosage used in research
Is it symptom-modifying, or is it truly disease modifying
Following the positive REDEFINE 1 Phase 3 data (published June 2025, PMID: 40544433), Novo Nordisk announced plans to file regulatory applications for CagriSema for obesity in the United States (FDA), European Union (EMA), and other major markets in 20252026
Only the agency makes such determinations, but some of the health claims combined with the nature of these peptides raise the question: could they cross the line from supplements into biological drug territory